BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld
Home
» New Cash in Hand, Threshold Plans Hypoxia Cancer Efforts
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
New Cash in Hand, Threshold Plans Hypoxia Cancer Efforts
Oct. 1, 2009
By
Catherine Hollingsworth
No Comments
Threshold Pharmaceuticals Inc. plans to raise about $35 million through the sale of stock and warrants, money that will help advance its cancer drug pipeline and extend its cash well into 2011. (BioWorld Today)
BioWorld